Menu Back to 2nd-DIA-Advanced-Regulatory-Affairs-Training-Course-in-Japan

Program Committee

  • Yomei  Matsuoka, MSc, RPh
    Yomei Matsuoka, MSc, RPh Department of Clinical Medicine (Pharmaceutical Medicine)
    Graduate School of Pharmaceutical Science, Kitasato University, Japan
  • Satoshi  Fukunaga, PhD
    Satoshi Fukunaga, PhD
    UCB Japan Co., Ltd., Japan
  • Teruyo  Arato, PhD
    Teruyo Arato, PhD Professor, Department of Regulatory Science
    Hokkaido University Graduate School of Medicine, Japan
  • Yoshikata  Furuya, MSc
    Yoshikata Furuya, MSc Director, Vaccine Policy, Health Policy
    MSD K.K., Japan
  • Toshiko  Ishibashi
    Toshiko Ishibashi
    AbbVie GK, Japan
  • Takaaki  Ishine
    Takaaki Ishine Senior Clinical Research Specialist
    MSD K.K., Japan
  • Kiyohito  Nakai, PhD
    Kiyohito Nakai, PhD Director, Pharmaceutical and Food Safety Bureau
    Ministry of Health, Labour and Welfare, Japan
  • Yuko  Owada
    Yuko Owada RA Functions Dept.
    Novartis Pharma K.K., Japan
  • Norikazu  Takahata
    Norikazu Takahata President
    Plus Action for Children, Japan
  • Nao  Tsuchida, MD, PhD
    Nao Tsuchida, MD, PhD Chief
    National Hospital Organization Headquarters, Japan
  • Yoshiaki  Uyama, PhD
    Yoshiaki Uyama, PhD Director, Office of Medical Informatics and Epidemiology
    Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Load More